PET/CT Scan-Guided Watchful Waiting or Neck Dissection of Locally Advanced Lymph Node Metastases in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Primary Head And Neck Cancer
NCT00720070 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 560
Last updated 2013-08-26
Summary
RATIONALE: Imaging procedures, such as PET/CT scan, produce pictures of areas inside the body and may help doctors detect residual disease and plan the best treatment. Neck dissection is surgery to remove lymph nodes and other tissues in the neck. It is not yet known whether a neck dissection should always be performed in treating patients with head and neck cancer.
PURPOSE: This randomized phase III trial is studying PET/CT scan-guided watchful waiting compared with neck dissection of locally advanced lymph node metastases in treating patients who are undergoing chemotherapy and radiation therapy for primary head and neck cancer.
Conditions
Interventions
- PROCEDURE
-
positron emission tomography/computed tomography
Patients undergo PET/CT scan
- PROCEDURE
-
therapeutic conventional surgery
Patients undergo neck dissection
Sponsors & Collaborators
-
Warwick Medical School
lead OTHER
Principal Investigators
-
Hisham Mehanna, MD · Warwick Medical School
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-09-30
- Primary Completion
- 2012-08-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer
NCT07285564 ·Status: RECRUITING ·Phase: NA
-
FDG-PET/CT in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed H&N Cancer
NCT00983697 ·Status: UNKNOWN ·Phase: NA
-
Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases
NCT05408871 ·Status: TERMINATED ·Phase: PHASE1
-
Measurement of Head and Neck Tumor Hypoxia With PET-MRI
NCT05246475 ·Status: RECRUITING ·Phase: NA
-
Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma
NCT00634777 ·Status: UNKNOWN ·Phase: NA
-
Pseudo-Simultaneous Imaging of Tumor Hypoxia and Proliferation in HNC Patients Using PET/CT
NCT03548727 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Phase III Trial of PET/CT vs. CTSurveilance for Head and Neck Cancer
NCT02655068 ·Status: TERMINATED ·Phase: PHASE3
-
Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.
NCT00782691 ·Status: UNKNOWN
-
PET With [18F]HX4 in Head and Neck Cancer
NCT01347281 ·Status: COMPLETED ·Phase: NA
-
Dynamic Contrast Enhanced Computed Tomography (CT) for Head and Neck Cancer
NCT01549379 ·Status: TERMINATED ·Phase: NA
-
Detection of Cervical Lymph Node Metastases With a High-Resolution Positron Emission Tomography (PET) Imaging System
NCT01030497 ·Status: COMPLETED
-
Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma
NCT01836484 ·Status: COMPLETED
-
Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer
NCT00671437 ·Status: COMPLETED ·Phase: PHASE2
-
Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT01179360 ·Status: COMPLETED
-
PET/CT to Image Hypoxia in Head and Neck Tumours
NCT00395109 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Use of PET-MR in Head and Neck Cancer Patients - Diagnostic and Therapeutic Applications
NCT06032663 ·Status: RECRUITING ·Phase: NA
-
PET/MR in Radiotherapy for Head and Neck Cancer Pilot
NCT02952625 ·Status: COMPLETED ·Phase: NA
-
PET/CT Follow up for Head and Neck Squamous Cell Carcinoma
NCT05707078 ·Status: RECRUITING ·Phase: NA
-
Validation of USPIO-enhanced MRI for Detection of Lymph Node Metastases in Head and Neck Carcinoma
NCT03817307 ·Status: UNKNOWN ·Phase: NA
-
PET/CT: Role in Detecting Unknown Primary Head and Neck Cancer
NCT00656760 ·Status: COMPLETED ·Phase: NA
-
PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning
NCT03286972 ·Status: TERMINATED
-
Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
NCT06914999 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy
NCT00809016 ·Status: COMPLETED ·Phase: NA
-
Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT
NCT05068687 ·Status: COMPLETED ·Phase: NA
-
18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
NCT04813705 ·Status: RECRUITING ·Phase: PHASE2